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Abstract
Purpose The purpose of this study was to report outcomes
of infectious scleritis after pterygium surgery, managed with
antibiotic therapies and early scleral debridement.
Methods Retrospective chart review of 13 consecutive cases
of infectious scleritis after pterygium excision between 1999
and 2009 was conducted. Collected data included prior
medical and surgical history, latency period between ptery-
gium surgery and presentation of infectious scleritis, culture
and histopathologic findings, antibiotic regimen, length of
hospital stay, visual acuity before and after treatment, and
complications.
Results Median follow-up was at 14 months. Twelve
patients underwent prompt surgical debridement after infec-
tious scleritis diagnosis (median, 2.5 days). Debridement
was delayed in one patient. Median hospital stay was 3 days.
Best-corrected visual acuity improved in ten patients,
remained stable in one patient, and decreased in two patients
following treatment. Complications included scleral thin-
ning requiring scleral patch graft (1/13), glaucoma (3/13),
and progression to phthisis bulbi (1/13). No patients re-
quired enucleation.
Conclusions In contrast to the generally poor outcomes in
the literature, early surgical debridement of pterygium-
associated infectious scleritis appears to offer improved
prognosis.
Keywords Infectiousscleritis.Pterygiumexcision.
Surgicaldebridement.Biofilm
Introduction
Infectious scleritis is an uncommon inflammatory disease
that often results in destructive complications, including loss
of the affected eye [1]. Infectious scleritis can be classified
as either primary, following local infection, usually after
violation of scleral integrity, or secondary, from extension
or dissemination of infection from another site [2–5].
Though rare, infectious scleritis is a well-documented com-
plication of pterygium excision that may emerge as late as
two to four decades postoperatively [6, 7]. Adjunctive ther-
apies, such as β-irradiation, mitomycin C, and excessive
cauterization, have been implicated in the pathogenesis of
infectious scleritis after pterygium excision.
Medical management of infectious scleritis typically
results in poor prognosis [4]. Surgical debridement, when
performed, is often delayed, and these cases are frequently
characterized by extended hospitalizations, deleterious com-
plications, and dismal visual outcomes [6–9]. Prompt surgi-
cal debridement and appropriate antibiotic coverage have
been associated with better outcomes. Here, we evaluated
long-term outcomes in a cohort of patients with infectious
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gical debridement and fortified antibiotics.
Methods
This is a retrospective review of 13 consecutive patients
diagnosed with infectious scleritis following pterygium ex-
cision and referred to the Doheny Eye Institute Cornea
Service from 1999 to 2009. All pterygium excisions were
performed at outside facilities. This Institutional Review
Board-approved study followed the tenets of the Declaration
of Helsinki; chart review was performed in accord with the
Health Insurance Portability and Accountability Act of
1996.
Diagnosis of infectious scleritis was established by four
corneal specialists (SCY, JCS, JAI, RES) based on present-
ing signs and symptoms and, in some cases, positive bacte-
rial culture of scleral materials. Cases with negative culture
results were included if there was high clinical suspicion for
infectious scleritis, e.g., history of pterygium excision, pres-
ence of purulent materials, response to antibiotics, or sug-
gestive histopathologic findings. All of our patients were
referredfromoutsidefacilities,andamajorityofthesepatients
was already on topical antibiotics
Charts were reviewed, and demographic and clinical
information, including age, sex, past medical and ocular
history, the ophthalmologic examination, surgical proce-
dures, treatment strategies, and outcomes, were collected
and stored in an anonymous electronic database. Results of
diagnostic procedures, namely culture and antibiogram of
scleral material excised during surgical debridement and
histopathologic examination of biopsied tissue, were also
gathered and recorded similarly. Operative records from
each patient's previous pterygium surgery at other centers
were unavailable, but any relevant information disclosed by
the patient and documented in the chart was also collected.
Common descriptive statistical methods (mean, median,
standard deviation) were used for data analysis.
Technique of scleral debridement
All patients received general anesthesia, followed by prep-
aration of the affected eye with 5% povidone–iodine solu-
tion and standard sterile technique. After placement of a
wire lid speculum, the conjunctiva was approached superi-
orly with a peritomy, using Westcott scissors. The necrotic
tissue and abscess materials were dissected under ste-
reotactic microscopy with a Beaver 66 surgical blade
and scissors, until the choroidal pigmentation was visi-
ble through the scleral fibers. No globe penetration occurred
in any case. In cases that involved the sclera beneath the
rectus muscle, the muscle was detached and re-anchored
with interrupted 8-0 Vicryl sutures to healthy sclera after
complete debulking of the underlying necrotic tissue. Occa-
sional gentle hemostasis was achieved using bipolar
cautery. After debridement, the surgical defect was left
exposed, without primary closure, to ensure good expo-
sure to the topical fortified antibiotics. In one case (patient 3),
an amniotic membrane graft was used. The conjunctival
edge was tucked down and anchored with interrupted 8-0
Vicryl sutures. Subconjunctival injection of vancomycin
(14 mg/mL) and tobramycin (25 mg/mL) was performed.
Bacitracin ointment was dispensed over the ocular surface,
and the eye was protected with a light-pressure eye patch and
shield for 24 h.
Results
A total of 13 patients were included in the study (Table 1).
The median age at presentation was 68 years (mean,
69.5 years; range, 49–92 years). Seven (54%) patients were
female, and six (46%), male. Past medical history was
significant for diabetes mellitus in five patients (38.5%).
Two patients reported adjunctive mitomycin C treatment,
and one reported β-irradiation treatment at the time of
pterygium resection. Elapsed time between pterygium exci-
sion and onset of infectious scleritis ranged from 4 months
to 20 years. All patients were referred to our tertiary care
center; ten patients already had received treatment from the
referring physicians, such as topical and oral antibiotics,
with or without corticosteroids.
Once the patients arrived at our institution, 12 out of 13
underwent prompt surgical debridement. For the remaining
patient, debridement was delayed for 32 days because of an
unusual calcific plaque overlying the affected area and an
initial dramatic improvement on topical fortified antibiotics
alone. Excluding this outlier, the median length of time
between presentation and debridement was 2.5 days (range,
0–18 days).
Cultures of scleral scrapings were positive for Pseudo-
monas sp. in seven cases, Eikenella corrodens in one patient
(6), Streptococcus viridans in one patient (9), and Staphylo-
coccus aureus in one patient (10). Histopathological reports
were available for 11 of the 13 patients, revealing acute
suppurative inflammation in ten cases and chronic inflam-
matory infiltrate in eight cases. Special stains for bacteria
(Gram) and fungi (Gomori methenamine silver) were docu-
mented as negative in seven specimens.
All patients received antibiotic therapy (Table 2) in addi-
tion to surgical debridement. In all cases, patients initially
received fortified topical eye drops every hour for several
days. Tobramycin was used in all cases, in combination with
vancomycin, cefazolin, and/or piperacillin. Eleven patients
also received systemic IVand/or oral antibiotics. The use of
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J Ophthal Inflamm Infect (2012) 2:81–87 83systemic antibiotics was guided by each patient's clinical
presentation and course. The antibiotic regimens were ad-
justed according to clinical course and availability of culture
and antibiogram.
Two patients (1 and 10, Table 1) presented with history of
rheumatoid arthritis and pterygium excision, which compli-
cated the diagnostic algorithm. Nonetheless, the scleral
scrape cultures were positive for bacteria in both. The
presenting clinical features of patient 1 were especially
complicated, including severe intraocular inflammation
and choroidal and retinal double detachments. She ulti-
mately required a second surgical debridement, 8 days after
the first, with excellent visual restoration. Patient 9 also
required a second debridement, 28 days after the first. Pa-
tient 8 presented with the clinical picture of endophthalmitis
and angle-closure glaucoma, so surgical intervention was
Table 2 Treatment outcomes after debridement and antibiotic therapy for infectious scleritis
Patient Hospital
stay
(days)
Complications Antibiotic therapy BCVA
before
debridement
BCVA after
debridement
Follow-
up
(months)
1 21 Bleeding, scleral thinning, glaucoma,
recurrence
Ciprofloxacin IV, gentamicin IV, tobramycin/
dexamethasone gtts, ciprofloxacin ointment,
fortified topical cefazolin and tobramycin and
vancomycin and piperacillin gtts,
ciprofloxacin ointment, ciprofloxacin PO
HM 20/50 −28 6
2 2 Severe scleral thinning, involvement
of sclera at medial rectus
Levofloxacin IV, tobramycin/dexamethasone
gtts, moxifloxacin gtts, gatifloxacin gtts
20/100 20/40 30
3 1 Scleral thinning, involvement of sclera
at medial rectus
Fortified topical vancomycin and tobramycin
gtts, gatifloxacin gtts, ciprofloxacin PO
20/200 20/50 4
4 1 Scleral thinning Levofloxacin IV, fortified topical vancomycin
and tobramycin gtts, gatifloxacin gtts,
ciprofloxacin ointment
20/100 −1 20/40 +2 14
5 3 Scleral thinning, entropion, posterior
synechiae
Cefazolin IV, fortified topical vancomycin and
tobramycin gtts, ciprofloxacin gtts,
moxifloxacin gtts
LP CF 4
6 2 Severe scleral thinning requiring
scleral patch graft and patch graft
revision, involvement of sclera at
medial rectus
Fortified topical vancomycin and tobramycin
gtts, gatifloxacin gtts, gentamicin ointment,
levofloxacin PO
20/100 20/50 +1 5
7 1 Scleral thinning, corneal necrosis with
iris adhesion, prolapsed vitreous,
elevated IOP
Levofloxacin IV, Fortified topical vancomycin
and tobramycin gtts, gatifloxacin gtts,
moxifloxacin gtts, moxifloxacin PO,
fluconazole PO, doxycyclin PO
LP LP 4
8 7 Severe scleral thinning, glaucoma Gentamicin IV, ciprofloxacin IV, fortified
topical tobramycin and vancomycin gtts,
moxifloxacin gtts, loteprednol/tobramycin
gtts, ciprofloxacin ointment, ciprofloxacin PO
3/200 20/30 −22 6
9 5, 1 Scleral thinning, recurrence Fortified topical vancomycin and tobramycin
gtts, moxifloxacin gtts, gatifloxacin gtts,
ofloxacin gtts, ciprofloxacin gtts
20/200 HM 44
10 0 Scleral thinning, perforation, corneal
haze, corneal epithelial defect that
resolved
Fortified topical tobramycin and cefazolin gtts,
ofloxacin gtts
20/50 20/25 +1 62
11 14 Scleral thinning, choroidal
detachment, involvement of sclera
under medial rectus
Ciprofloxacin IV, fortified topical tobramycin
and piperacillin gtts, tobramycin/
dexamethasone gtts, levofloxacin gtts,
ofloxacin gtts
20/80 +2 20/60 +1 6
12 4 Scleral thinning, hypertrophic
conjunctival growth, choroidal
detachments, serous retinal
detachment
Ciprofloxacin IV, fortified topical tobramycin
gtts, levofloxacin gtts
20/25 20/20 13
13 10 Scleral thinning, phthisis Fortified topical tobramycin and vancomycin
gtts, levofloxacin gtts, ciprofloxacin ointment,
ciprofloxacin PO, erythromycin gtts
CF @ 5′ NLP 102
gtts eye drops, IOP intraocular pressure, BCVA best-corrected visual acuity, LP light perception, CF counting finger, HM hand motion, NLP no light
perception
84 J Ophthal Inflamm Infect (2012) 2:81–87delayed 14 days, until the diagnosis of infectious scleritis was
confirmed. Overall, the median hospital stay was 3 days
(mean, 6.7 days; range, 0 to 21 days).
Globe preservation was achieved in all 13 eyes, de-
spite scleral thinning in each case (Table 2 and Fig. 1).
There was documented necrosis of the sclera under the
medial rectus in four patients, requiring the muscle to
be detached for debridement. The medial rectus was
then transfixed to the adjacent healthy sclera using interrup-
ted 8-0 Vicryl sutures. Over the follow-up period (mean
follow-up of 11.25 months), these patients did not com-
plain of diplopia despite good visual rehabilitation (20/
40 to 20/60).
Preoperative best-corrected visual acuity (BCVA)
ranged from 20/25 to light perception (Table 2). Post-
operative BCVA ranged from 20/20 to no light percep-
tion (patient 13). Ten patients demonstrated improvement in
their BCVA; one patient's BCVA remained unchanged.
Two patients (9 and 13), whose preoperative visual acuities of
20/200 and counting fingers at 5 ft, respectively, de-
creased to hand motion and no light perception, respective-
ly, at last visit.
Discussion
We report improved outcomes of infectious scleritis after
pterygium excision managed with prompt, aggressive scler-
al debridement and antibiotic therapy, and we contend that
delayed debridement may carry worse outcomes. None of
the patients in our series required enucleation; 11 of the 13
patients demonstrated stable or improved visual acuity, and
the median hospital stay of our patients was 3 days. Other
investigators have demonstrated higher complication rates,
poorer visual outcomes, and longer hospital stays for the
treatment of infectious scleritis.
In one review of 28 patients with culture-proven infectious
keratoscleritis, 88% of patients who initially underwent
medical management by topical, intravenous, or subconjunc-
tival fortified antibiotic regimens eventually required eviscer-
ation (Table3)[ 4].While surgical interventioncombinedwith
antibiotics was associated with improved outcomes, enucle-
ation was still necessary in 18% of these cases. Lin et al. [6]
reported an average hospitalization of 32.5 days, and 62% of
their patients required repeated debridements. Hsiao et al. [7]
reported various complications: serous retinal detachment
(11%), choroidal detachment (17%), double detachment
(11%), complicated cataracts (28%), recurrence of initial in-
fection (22%), and eventual evisceration (22%). Only 61% of
their patients regained some useful vision; all were initially
treated with antibiotics, and 78% eventually required opera-
tive management. In one retrospective study of 16 infectious
scleritis cases over a 10-year period, nine patients received
only medical management; 22% of these patients eventually
required enucleation, and only 22% attained a BCVA ofbetter
than 2/200, with an average hospitalization of 21.2±4.8 days
[8]. A more recent study reported the application of subpalpe-
bral antibiotic lavage in six patients who had demonstrated no
clinical improvement while on topical fortified antibiotics [9].
All six patients had resolution of infectious keratoscleritis;
unfortunately, more than half of these patients required corne-
al transplant, cataract extraction, glaucoma aqueous shunt, or
some combination of these surgical treatments. In a series of
three cases of post-pterygium excision Pseudomonas sp.k e r -
atoscleritis, Huang and colleagues reported the use of inten-
sive topical and systemic antibiotics, low-dose oral
prednisolone,andearlysurgicaldebridement[10].Therewere
no cases of recurrence or evisceration; however, the BCVA
remained suboptimal, ranging from 20/120 to 20/400. The
lower threshold for surgical intervention in this current study
appears to correlate with better postoperative BCVA, 100%
globe preservation rate, fewer complications, and shorter hos-
pital stays when compared to the literature.
As previously reported, Pseudomonas sp. was the most
commonly isolated organism in our series. Pseudomonas
has been associated with more aggressive scleral infection
and a dismal prognosis [4]. Other organisms are tabulated in
Table 1. Interestingly, Streptococcus viridans and Staphylo-
coccus aureus were isolated from patients 9 and 10, respec-
tively. It is unclear if these organisms represented the true
infectious agents or contaminations from normal flora. E.
corrodens, a gram-negative rod rarely recovered in soft
tissue infections, was isolated from patient 6 [11].
Even though no microorganisms were observed on histo-
pathologic evaluation of the scleral specimens, most revealed
acute, necrotizing (suppurative) inflammation, and many had
a mixed acute–chronic infiltrate consistent with bacterial
infections scleritis [12]. A possible explanation would be
administration of topical antibiotics by the referring physi-
cians and implementation of aggressive antibiotic regimen
prior to surgical debridement at our institution.
Fig. 1 Severe thinning of the sclera following debridement of infec-
tious scleritis
J Ophthal Inflamm Infect (2012) 2:81–87 85During debridement, the surgeons noted small pockets of
abscess within the necrotic sclera and beneath areas of
seemingly healthy sclera, consistent with two previous
reports [6, 12]. All of the patients in this series had a history
of pterygium excision. The latency period between ptery-
gium resection and scleral infection in our series, 4 months
to 20 years, is comparable to the literature [6]. Application
of adjunctive therapies such as mitomycin C and b-radiation
at the time of pterygium has been implicated in the patho-
genesis of scleral infection through destruction of the pro-
tective blood supply to the conjunctiva and outer sclera.
Diabetes mellitus, another possible risk factor predisposing
patients to infectious scleritis [13], was present in five (38%)
of our cases.
Biofilm formation may also be implicated in the refrac-
tory nature of infectious scleritis to medical management
alone. In the human body, bacteria exist predominantly in
two states: planktonic and sessile [14]. Planktonic forms are
highly susceptible to antibiotics and host defenses, whereas
sessile forms are more resistant. The sessile form is seen
mainly as a biofilm on the surfaces of implanted devices or
biologic tissues. Within the biofilm architecture, bacterial
colonies are encased in an extracellular matrix of exopoly-
saccharides, which provide protection from hostile environ-
ments. The inner, sessile, oxygen-deprived microcolonies
have limited mobility, a slow growth rate, a different syn-
thetic rate, and a reduced susceptibility to antibiotics [15].
For some antibiotics, the concentration required to penetrate
the biofilm can be thousands of times the concentration
required for planktonic bacteria of the same strain [14, 16,
17]. The biofilms may evolve into a physically diverse
structure containing channels and interstitial voids, as pre-
viously reported [12]. Thus, physiological heterogeneity
within a bacterial colony and pharmacokinetic limitations
are possible explanations for the frequent failure of antibi-
otic treatment alone in the management of infectious scler-
itis [18–20]. Accordingly, early surgical debridement may
be important in disrupting the barriers to antibiotic efficacy.
This was our rationale for a lower threshold for surgical
debridement in this study.
After debridement, we decided against the use of cryo-
preserved human amniotic membrane graft on the exposed,
Table 3 A comparison of treatment outcomes of infectious scleritis reported in other studies
Study Number of
patients
At least one
debridement
Repeat
debridement
Postoperative
BCVA (%)
Mean hospital
stay (days)
Postoperative complications
(%)
Enucleations or
eviscerations
Reynolds and
Alfonso [4]
28 39% N/A N/A N/A N/A 32%
Lin et al. [6] 30 87% 62% N/A 32.5 N/A 3.3%
Hsiao et al. [7] 18 33% N/A NLP (22) N/A Recurrence (22) 22%
LP (5.5) Complicated cataract (28)
HM (5.5) Serous retinal detachment (22)
CF (5.5)
20/400 (5.5) Choroidal detachment (17)
20/200 (28)
20/100 (11) Choroidal and retinal
detachment simultaneously
(11)
20/50 (11)
20/30 (5.5)
Huang et al. [10] 3 100% 0% 20/200 (67) N/A Posterior synechiae (67) 0%
20/120 (33) Cataract (67)
Cystoid macular edema (67)
Huang et al. [8] 16 44% 13% NLP (19) N/A Vitreous opacity (50) 19%
LP (19) Glaucoma (25)
HM (6) Serous retinal or choroidal
detachments (25) 0.02 (6)
0.1 (13)
0.2 (6) Cataract (13)
0.3 (6) Recurrence (13)
0.5 (6)
0.6 (6)
N/A (13)
BCVA best-corrected visual acuity, N/A not available, NLP no light perception, LP light perception, HM hand motion
86 J Ophthal Inflamm Infect (2012) 2:81–87debrided area in all but one patient (3). Maximum exposure
is desirable for topical antibiotic penetration and prevention
of incubation of any microbes remaining at the surgical site.
Hydration of the bare and thinned sclera with continual
medical therapy has been suggested as an effective modality
to facilitate re-epithelialization of the sclera after bare sclera
excision of pterygium [21]. Second, we wanted to avoid
obscuring visualization of early recurrence or the formation
of abscesses [6, 22]. Adequate re-epithelialization of the
exposed sclera was observed in 12 eyes shortly after de-
bridement. For patient 3, however, a human amniotic mem-
brane graftwasdeemedappropriatebecausere-epithelialization
did not appear likely to occur due to the severity of scleral
thinning [21].
As previously discussed, none of the patients with in-
volvement of the sclera under the medial rectus complained
of diplopia following surgery, possibly indicating that they
were able to achieve fusion or that there was suppression of
the misaligned eye. Management of diplopia would involve
prism or strabismus surgery. However, surgical management
may not bea feasibleoptiongiven the poorstructuralintegrity
of the debrided eye (Fig. 1).
Thus, prompt and aggressive surgical debridement may
contribute to better outcomes in infectious scleritis after
pterygium excision. We postulate that the generally poor
outcomes reported in the literature may be related to the
limited penetration of antibiotics into bacterial microab-
scesses and biofilms in the nearly avascular, infected sclera
and to the delay in surgical intervention aimed at disrupting
these defenses and debulking the microbial load. Prospec-
tive, comparative studies may not be possible because this
disease entity has low incidence and high risks of permanent
vision impairment or loss of globe. As other studies reported
high rates of conversion to surgical debridement [4, 6–8],
we advocate vigilant monitoring and prompt debridement if
indicated.
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